课题基金 / 基金详情

Investigating autoimmune responses for tailoring biologic therapies in severe asthma

Investigating autoimmune responses for tailoring biologic therapies in severe asthma
研究自身免疫反应以调整严重哮喘的生物疗法
批准号:
413281
负责人:
Mukherjee Manali
金额:
$14.57万
依托单位:
依托单位国家:
加拿大
项目类别:
Salary Programs
财政年份:
2019
资助国家:
加拿大
项目状态:
已结题
起止时间:
2019-08-01 至 2021-08-01

项目摘要

项目成果

Mukherjee Manali的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Asthma can be very sever for approximately 10% of patients who suffer from significant symptoms, frequent hospitalizations, loss of productivity/income, and impose a significant economic burden. Severity is driven by a type of white blood cells (eosinophi
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
SARS-CoV-2 triggers Autoimmunity: implications for the pathogenesis of Post-Acute COVID-19 Syndrome - (AI-PACS)
  • 批准号:
    448905
  • 项目类别:
    Operating Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2021
  • 负责人:
    Mukherjee Manali
  • 依托单位:
Investigating local vs. systemic autoimmune pathomechanisms in complex airways disease
  • 批准号:
    376474
  • 项目类别:
    Fellowship Programs
  • 资助金额:
    $6.56万
  • 财政年份:
    2017
  • 负责人:
    Mukherjee Manali
  • 依托单位: